Skip to content
back

PDA 2026: Advancing small-batch device assembly

| 2 min read

Will we see you at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Palm Springs? We’re looking forward to showing the RMA live and engaging on production strategies for flexible assembly for clinical trials and small batches.

Join us at the PDA Universe of Pre-Filled Syringes Conference in Palm Springs to explore innovative production strategies for clinical trials and small batches.

Key takeaways

  • Live RMA demonstration for clinical-trial and small-batch assembly
  • Versatile processing of different pen and auto-injector products and formats
  • Exchange with Syntegon experts on manufacturing strategies and future scale-up

From October 6–7, the PDA Universe of Pre-Filled Syringes and Injection Devices Conference brings together pharmaceutical manufacturers, CDMOs, and technology providers to discuss the changing requirements of injectable drug delivery. At this year’s event in Palm Springs, Syntegon will focus on the challenges surrounding clinical-trial and small-batch manufacturing – from maintaining compliance and product quality to shortening time-to-clinic and preparing for new production requirements.

Experience the RMA live

At the center of Syntegon’s PDA presence is the RMA, a semi-automated assembly solution for pens and auto-injectors that is ideally suited for clinical trials and small-batch production. Its flexible and modular concept accommodates different products and formats, giving manufacturers the versatility required as device portfolios and market demands evolve. At the booth, visitors can experience the RMA live in operation and gain first-hand insights into its capabilities and benefits for flexible device assembly.

Key benefits of the RMA:

  • Versatile: Accommodates different products and formats.
  • Scalable: Enables the transition to higher-output equipment.
  • Flexible: Adapts to evolving production requirements.

The RMA also follows Syntegon’s scalable platform approach: Standardized assembly processes facilitate technology transfer to higher-output equipment when production scales and volumes increase, supporting the journey from clinical development toward commercial manufacturing.

contact-person

“Clinical development requires manufacturers to balance two needs: flexibility for today’s small volumes and a clear path toward commercial production. Choosing an assembly approach with scale-up in mind helps avoid unnecessary complexity as requirements evolve.”

Klaus Brinkrode, Sales Manager, North America

Local presence, global expertise

Beyond the technology on display, Syntegon experts will be available at PDA to discuss individual production challenges and manufacturing strategies. With experts and service capabilities in the U.S., Syntegon maintains close proximity to pharmaceutical manufacturers and CDMOs, and provides flexible support. By combining this local presence with global expertise in device assembly and extensive application know-how, Syntegon can support customers from early-stage clinical projects to future scale-up.

Visit Syntegon at booth #701 at PDA in Palm Springs, October 6-7, 2026, to experience the RMA live and meet the Syntegon experts.

Interested in our pharma solutions?

Interested in our pharma solutions?

Get in touch with us!
 
Worldwide contacts

Discover more about Syntegon

PDA 2026: Advancing small-batch device assembly

Join us at the PDA Universe of Pre-Filled Syringes Conference in Palm Springs to explore innovative production strategies for clinical trials and small batches.

RTU packaging: cooperation is key

RTU packaging for syringes, vials, and cartridges requires precise interaction between container and machine. Discover key challenges and solutions.

PACK EXPO: seamless pharma processes for North America

Discover Syntegon’s seamless pharma solutions at PACK EXPO 2026 in Chicago – from vial fill-finish and Annex 1 compliance to flexible OSD production.